FOLH1 and neoplasm: And predictors included in the nomograms were time since initial diagnosis of prostate cancer, chemotherapy status, baseline hemoglobin concentration, and [Ga-68] Ga-PSMA-11 PET/CT parameters (molecular imaging TNM classification and tumour burden).